Table 1 of
Li, Mol Vis 2023; 29:378-385. Table 1 of
Li, Mol Vis 2023; 29:378-385.
Table 1. General clinical data in the HL-B27+ AS-associated AAU and HCs groups.
| Clinical characteristics | HL-B27+ AS-associated AAU group (n=21) | HCs group (n=21) | Reference range | P value |
|---|---|---|---|---|
| Age (years) | 35.9±10.0 | 38.0±9.5 | NA | >0.05 |
| Sex (male/female) | 14/21 | 11/21 | NA | >0.05 |
| disease duration | 1.21 | NA | NA | NA |
| HLA-B27 positive | 21/21 | NA | NA | NA |
| Leukocytes (×109/L) | 7.63±2.24 | 5.88±1.27 | 4.0–10.0 | <0.05 |
| Neutrophils (×109/L) | 5.18±1.89 | 3.20±1.04 | 2.5–7.5 | <0.05 |
| Lymphocytes(×109/L) | 1.98±0.78 | 2.10±0.49 | 0.8–4.0 | >0.05 |
| Monocytes (×109/l) | 0.53±0.15 | 0.41±0.11 | 0.1–0.6 | <0.05 |
| Eosinophils(×109/l) | 0.15±0.11 | 0.13±0.07 | 0.05–0.5 | >0.05 |
| Basophils(×109/l) | 0.03±0.02 | 0.04±0.02 | 0–0.1 | >0.05 |